Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 103 results for "glaxosmithkline pte ltd"

GSK Pharma open offer: Good opportunity to exit
Chennai Online

GSK Pharmaceuticals: Updates on open offer

GlaxoSmithKline Pte Ltd has acquired 20,609,774 shares of GlaxoSmithKline Pharmaceuticals via open offer. Money Control, 1 month ago
GSK Pharma open offer: Good opportunity to exit Chennai Online, 2 months ago
MSN.co.in

GlaxoSmithKline takes firmer control over Indian operation

LONDONMarch 10 saw announce that after initiating a voluntary open offer through its subsidiary, GlaxoSmithKline Pte Ltd., it has increased its stake in its publicly-listed pharmaceuticals subsidiary in India, known as , from 50.7 percent to 75 ...
 Drug Discovery News1 month ago GSK Pharma's Rs 6,400cr open offer begins on Tuesday  Times of India2 months ago GSK Pharma's Rs.6,400 crore open offer begins Tuesday  ProKerala.com2 months ago GSK Pharma's Rs 6,400 cr open offer today  India TV1 month ago
[x]  
SWA

GSK acquires full control of RI unit

, 9:14 AM UK drug-maker GlaxoSmithKline (GSK) has acquired full ownership of its Indonesian consumer healthcare business. GSK Consumer Healthcare Pte. Ltd. bought a 30 percent share worth Rp 465 billion (US$41 million) from Sarasvati ...
 Jakarta Post1 week ago GSK Mengukuhkan Bisnis Consumer Healthcare di Indonesia  SWA2 weeks ago GSK acquires remaining 30% of its Indonesian Consumer Healthcare business  Pharma Letter3 weeks ago GSK acquires full ownership of Indonesian Consumer Healthcare business  Foodbev2 weeks ago
[x]  
India TV

GSK increases stake to 75% in Indian arm through open offer

GlaxoSmithKline plc (GSK) has increased its stake in Indian arm GlaxoSmithKline Pharmaceuticals, from 50.7 per cent to 75 per cent. GlaxoSmithKline Pharma will remain publicly-listed. David Redfern, chief strategy officer, GSK said: We are very ...
 PharmaBiz1 month ago GSK pays Rs 6400 crore to lift its stake in Indian subsidiary to 75%  India TV1 month ago GSK increases Indian stake to 75 percent  MedCity News1 month ago GSK increases stake in Indian pharmaceuticals subsidiary  Pharmacy.Biz1 month ago
[x]  
Livemint.com

Govt clears GlaxoSmithKline's Rs.6,400 crore FDI proposal

After the purchase, holding of the promoter group firm in the Indian subsidiary will go up to 75% from the current level of 50.67%. Photo: Hemant Mishra/Mint New Delhi: The government on Thursday cleared Rs. 6,400 crore foreign direct investment ...
 Livemint.com1 month ago Govt clears GlaxoSmithKline's Rs 6,400-cr FDI proposal  Smart Investor1 month ago CCEA clears GlaxoSmithKline's Rs6,400 crore FDI proposal  Money Life1 month ago

GSK pays $1bn to up stake in Indian arm to 75% from 50.7%

MUMBAI: GlaxoSmithKline Plc has increased its stake in its Indian pharma subsidiary, GlaxoSmithKline Pharmaceuticals, from 50.7% to 75%, following a recent open offer. The company announced that the subsidiary will remain publicly-listed. The offer ...
 Times of India1 month ago GLAXOSMITHKLINE PLC : GSK pays $1bn to up stake in Indian arm to 75% from 50.7%  4 Traders1 month ago

GSK ups stake in Indian arm via open offer

GlaxoSmithKline plc, on Monday, said it had successfully increased its stake in its publicly-listed Indian pharmaceuticals subsidiary GlaxoSmithKline Pharmaceuticals Ltd. from 50.7 per cent to 75 per cent. This was done by a voluntary open offer ...
 The Hindu1 month ago

GlaxoSmithKline Pharma nears three month low, falls 16% in one week

GlaxoSmithKline plc has successfully increased its stake in GlaxoSmithKline Pharmaceuticals, from 50.7% to 75%. SI Reporter | Mumbai March 10, 2014 Last Updated at 12:07 IST GlaxoSmithKline Pharmaceuticals is trading lower by 3% at Rs 2,570, ...
 Business Standard India1 month ago

GLAXOSMITHKLINE : Takes Control of Indonesian Consumer Healthcare Unit

By Ian Walker LONDON--GlaxoSmithKline PLC ( >>GlaxoSmithKline plc ) is taking full control of its Indonesian Consumer Healthcare business in a deal which includes selling a non-core brand and a manufacturing facility in the country. The ...
 4 Traders3 weeks ago GlaxoSmithKline Takes Control of Indonesian Consumer Healthcare Unit  ADVFN India3 weeks ago
[x]  

GSK Pharma dips ahead of closure of open offer

Email this Print GlaxoSmithKline Pharma (GSK) is trading lower by 3% at Rs 2,969, in otherwise firm market, ahead of closure of the open offer made by the Britain-based parent company to acquire additional stake in Indian arm tomorrow. The ...
 Smart Investor1 month ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less